Ventas, Inc. (VTR)
| Market Cap | 18.40B |
| Revenue (ttm) | 4.13B |
| Net Income (ttm) | -47.45M |
| Shares Out | 416.18M |
| EPS (ttm) | -0.12 |
| PE Ratio | n/a |
| Forward PE | 25.51 |
| Dividend | $1.80 (4.07%) |
| Ex-Dividend Date | Dec 30, 2022 |
| Volume | 2,126,651 |
| Open | 44.45 |
| Previous Close | 44.24 |
| Day's Range | 44.08 - 44.80 |
| 52-Week Range | 35.33 - 64.02 |
| Beta | 1.22 |
| Analysts | Buy |
| Price Target | 55.62 (+25.81%) |
| Earnings Date | May 4, 2023 |
About VTR
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: comb... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 25 analysts, the average rating for VTR stock is "Buy." The 12-month stock price forecast is $55.62, which is an increase of 25.81% from the latest price.
News
Ventas Declares First Quarter 2023 Dividend of $0.45 per Common Share
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that its Board of Directors has declared a quarterly dividend of $0.45 per common share. The dividend wil...
Ventas to Participate in Investor Meetings at Citi 2023 Global Property CEO Conference
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that management will make a presentation at the Citi 2023 Global Property CEO Conference (the “Citi Confe...
Ventas' (VTR) Q4 FFO and Revenues Beat, SHOP NOI Increases
Ventas' (VTR) Q4 results outshine estimates on better-than-anticipated revenues. The SHOP same-store NOI improves on strong pricing power and occupancy growth.
The 3 Best REITs to Buy for February 2023
The real estate investment trusts (REITs) strong operating performance in 2022 was a welcome sight for real estate investors. The best REITs emerged as the post-pandemic reopening catalyzed positive m...
Ventas (VTR) Q4 FFO and Revenues Beat Estimates
Ventas (VTR) delivered FFO and revenue surprises of 1.39% and 0.15%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Ventas Reports 2022 Fourth Quarter and Full Year Results and Provides 2023 Outlook
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today reported results for the fourth quarter and full year ended December 31, 2022. CEO Remarks “We are pleased to have ...
Why Earnings Season Could Be Great for Ventas (VTR)
Ventas (VTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Ventas Appoints J. Justin Hutchens, Executive Vice President, Senior Housing, to Additional Role of Chief Investment Officer
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that J. Justin Hutchens, Executive Vice President, Senior Housing, has been appointed to the additional...
Ventas Announces Fourth Quarter 2022 Earnings Release Date and Conference Call
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) will issue its fourth quarter 2022 earnings release after the close of trading on the New York Stock Exchange on Thursday, February 9, 2023. A conf...
Ventas Announces Tax Treatment Of 2022 Distributions
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (the “Company”) announced today the tax treatment of its 2022 distributions on the Company's common stock.
Ardent Health Services partners with SwitchPoint Ventures to launch healthcare innovation studio
NASHVILLE, Tenn.--(BUSINESS WIRE)--Ardent Health Services has partnered with SwitchPoint Ventures to launch an innovation studio focused on transforming healthcare delivery and administration. The p...
5 Must-Buy REITs for Your January Buy List
REITs (Real Estate Investment Trusts) are a great way investors gain gain exposure to the real estate market, without putting down a large chunk of money for an investment. These assets are currently ...
Cadence and Ardent Health Services Launch Remote Care Management Program to Improve Care and Outcomes for Patients Outside of Clinics
NEW YORK--(BUSINESS WIRE)--Cadence today announced a partnership with Ardent Health Services to implement a remote patient monitoring and responsive virtual care program across Ardent's operations, ...
Is It Wise to Retain Ventas (VTR) Stock in Your Portfolio?
A rise in healthcare spending by senior citizens, accretive investments in the R&I business and a solid balance sheet bode well for Ventas (VTR). Meanwhile, stiff competition and higher interest rates...
Ardent appoints Brad Hoyt, MD chief medical information officer
NASHVILLE, Tenn.--(BUSINESS WIRE)--Ardent Health Services has appointed Brad Hoyt, MD, as chief medical information officer (CMIO). In the new role, Dr. Hoyt will be part of Ardent's senior leadersh...
Jefferies: REITs sector is at an interesting crossroads— here's why
Jonathan Peterson, Jefferies managing director, joins 'Power Lunch' to discuss Peterson's thoughts on real estate investment trusts, the subtypes within the hospital sector and more.
HealthTrust and Ardent Health Services Renew Long-Standing GPO Agreement
NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthTrust Performance Group, a comprehensive healthcare improvement organization, and Ardent Health Services, one of the largest private integrated health system...
Ventas Declares Fourth Quarter 2022 Dividend of $0.45 per Common Share
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that its Board of Directors has declared a quarterly dividend of $0.45 per common share. The dividend w...
Ardent Health Services and BioIntelliSense Launch State-of-the-Art Continuous Inpatient Monitoring Initiative to Advance Care and Optimize Workflow
NASHVILLE, Tenn. & DENVER--(BUSINESS WIRE)--Ardent Health Services and BioIntelliSense today announced the launch of a new continuous patient monitoring initiative to empower clinicians with greater...
Ventas Recognized for Industry ESG Leadership in 2022
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) has continued its Environmental, Social and Governance (ESG) leadership, earning its sixth consecutive Nareit Health Ca...
Ventas to Participate in Investor Meetings at Nareit's REITworld 2022 Annual Conference
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that management will participate in investor meetings at Nareit's REITworld 2022 Annual Conference (the...
Ventas' (VTR) Q3 FFO Meets, Revenues Beat, SHOP NOI Rises
Ventas (VTR) reports better-than-anticipated revenues. The SHOP same-store NOI improves on solid demand and pricing power.
Ventas (VTR) Q3 FFO Meet Estimates
Ventas (VTR) delivered FFO and revenue surprises of 0% and 0.49%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Ventas Reports 2022 Third Quarter Results
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today reported results for the third quarter ended September 30, 2022.
What's in the Offing for Ventas (VTR) This Earnings Season?
Ventas' (VTR) Q3 earnings are likely to have benefited from the occupancy growth of its SHOP portfolio. However, elevated expenses and higher interest rates might have been a spoilsport.